Global Pharmatech, Inc.
GBLP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $30 | $21 | $33 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $328 | $142 | $137 | $1 |
| Inventory | $28 | $31 | $23 | $0 |
| Other Curr. Assets | $1 | $2 | $1 | $0 |
| Total Curr. Assets | $387 | $195 | $194 | $1 |
| Property Plant & Equip (Net) | $84 | $105 | $127 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $101 | $0 |
| Long-Term Investments | $0 | $5 | $5 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $281 | $101 | $0 | $0 |
| Total NC Assets | $365 | $211 | $234 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $752 | $406 | $428 | $1 |
| Liabilities | – | – | – | – |
| Payables | $430 | $0 | $236 | $1 |
| Short-Term Debt | $80 | $0 | $50 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $181 | $0 | $170 | $0 |
| Other Curr. Liab. | $181 | $607 | $169 | $50 |
| Total Curr. Liab. | $872 | $607 | $624 | $51 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $872 | $607 | $624 | $51 |
| Equity | – | – | – | – |
| Pref Stock | $10 | $10 | $8 | $8 |
| Common Stock | $153 | $158 | $39 | $28 |
| Retained Earnings | -$12,243 | -$11,994 | -$11,973 | -$11,377 |
| AOCI | $21 | -$96 | -$4 | -$113 |
| Other Equity | $11,939 | $11,722 | $11,735 | $11,406 |
| Total Equity | -$120 | -$201 | -$196 | -$49 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $752 | $406 | $428 | $1 |
| Net Debt | $51 | -$21 | $17 | $0 |